Top Markets
Coin of the day
Cortexyme, Inc. Cortexyme, Inc.

Cortexyme, Inc.

CRTX
Peringkat dalam Saham #25185
Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to... Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to pioneering new therapies for Alzheimer's and various other degenerative conditions. The company's primary investigational drug, atuzaginstat (also known as COR388), is an orally delivered, small molecule inhibitor engineered to cross the blood-brain barrier and target gingipain. This compound is currently in Phase II/III clinical trials, where it is being assessed for its potential use in individuals with mild to moderate Alzheimer's disease, as well as for tackling oral squamous cell carcinoma, periodontitis, and coronavirus infections. Established in 2012, Cortexyme, Inc. is headquartered in South San Francisco, California.
Harga Saham
$1.95
Terakhir disinkronkan: 2022-07-29
Kapitalisasi Pasar
$52.48M
Perubahan (1 hari)
2.63%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Cortexyme, Inc. (CRTX)

Kategori

Riwayat pemecahan saham untuk Cortexyme, Inc. (CRTX)
Saham Cortexyme, Inc. (simbol: CRTX) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 21, 2026.
Satu lembar saham CRTX yang dibeli sebelum Aug 21, 2026 sekarang setara dengan 0 lembar saham CRTX.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US